Baldwin, Laura-Mae http://orcid.org/0000-0002-2236-1216
Schneider, Jennifer L.
Schwartz, Malaika
Rivelli, Jennifer S.
Green, Beverly B.
Petrik, Amanda F.
Coronado, Gloria D.
Funding for this research was provided by:
Centers for Disease Control and Prevention (U48DP005013)
Article History
Received: 27 April 2019
Accepted: 23 December 2019
First Online: 21 February 2020
Ethics approval and consent to participate
: This research was approved by the University of Washington Human Subjects Division, IRB ID 00000472. Verbal consent was obtained from all participants as approved by the University of Washington Human Subjects Division. Data were kept confidential by the study team.
: Participants gave consent for direct quotes from their interviews to be published in this manuscript. During the informed consent process, they were informed that: “Portions of the interview transcripts may be included in written manuscripts and presentations. No names will be included in manuscripts or presentations.”
: From November 2014–August 2015, Dr. Coronado served as a Co-Investigator on an industry-funded study to evaluate patient adherence to an experimental blood test for colorectal cancer. The study was funded by EpiGenomics. From September 2017–June 2018, Dr. Coronado served as the Principal Investigator on an industry-funded study to compare the clinical performance of an experimental FIT to an FDA-approved FIT. This was funded by Quidel Corporation. All other authors declare that they have no competing interests.